The chemiluminescence immunoassay analyzers market is expanding as hospitals, diagnostic laboratories, and pharmaceutical companies need faster, more accurate, and more automated testing systems. The market was valued at USD 13.6 billion in 2024 and is projected to reach USD 28.98 billion by 2035, growing at a CAGR of 7.12%. 1053 Chemiluminescence immunoassay, commonly called CLIA, uses a...